I agree that this site is using cookies. You can find further informations here.
X
Darrow, Jonathan J.
110  results:
Search for persons X
?
1

Patient perspectives on evidence supporting drug safety and..:

Rand, Leah Z. G. ; McGraw, Sarah ; Wang, Junyi...
Journal of the American Geriatrics Society.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

Leah Z. Rand, Daniel P. Carpenter, Aaron S. Kesselheim, Anu..:

Rand, Leah Z. ; Carpenter, Daniel P. ; Kesselheim, Aaron S....
Hastings Center Report.  54 (2024)  2 - p. 44-45 , 2024
Link: https://doi.org/10.1002/..
 
?
3

Trust in the Food and Drug Administration: A National Surve..:

Feldman, William B. ; Rand, Leah Z. ; Carpenter, Daniel...
Clinical Pharmacology & Therapeutics.  116 (2024)  2 - p. 408-414 , 2024
Link: https://doi.org/10.1002/..
 
?
4

CRISPR-phage antibacterials to address the antibiotic resis..:

Pacia, Danielle M ; Brown, Beatrice L ; Minssen, Timo.
Journal of Law and the Biosciences.  11 (2024)  1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
5

Variation in Endpoints in FDA Medication Approvals: A Revie..:

Sharpless, Leigh K. ; Kesselheim, Aaron S. ; Orr, Serena L..
Neurology.  101 (2023)  10 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
6

Pharmaceutical Innovation in Latin America and the Caribbea:

Vargas, Verónica ; Darrow, Jonathan
Journal of Law, Medicine & Ethics.  51 (2023)  S1 - p. 148-162 , 2023
Link: https://doi.org/10.1017/..
 
?
7

An Empirical Review of Key Glucose Monitoring Devices: Prod..:

Darrow, Jonathan J. ; Van de Wiele, Victor ; Beran, David.
Journal of Diabetes Science and Technology.  , 2023
Link: https://doi.org/10.1177/..
 
?
8

Physician Perspectives on the Food and Drug Administration'..:

Dhruva, Sanket S. ; Kesselheim, Aaron S. ; Woloshin, Steven...
Clinical Pharmacology & Therapeutics.  114 (2023)  3 - p. 614-617 , 2023
Link: https://doi.org/10.1002/..
 
?
9

Prioritizing Early Disease Intervention:

Caicedo, H. Hugo ; Darrow, Jonathan J. ; Caicedo, Julio C..
Therapeutic Innovation & Regulatory Science.  57 (2023)  6 - p. 1148-1152 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Securing the Trustworthiness of the FDA to Build Public Tru..:

Rand, Leah Z. ; Carpenter, Daniel P. ; Kesselheim, Aaron S....
Hastings Center Report.  53 (2023)  S2 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
11

Experts' Views on FDA Regulatory Standards for Drug and Hig..:

Dhruva, Sanket S. ; Darrow, Jonathan J. ; Kesselheim, Aaron S..
Journal of General Internal Medicine.  37 (2022)  16 - p. 4176-4182 , 2022
Link: https://doi.org/10.1007/..
 
?
12

Incremental benefits of novel pharmaceuticals in the UK: a ..:

Polak, Tobias B ; Cucchi, David GJ ; Darrow, Jonathan J.
BMJ Open.  12 (2022)  4 - p. e058279 , 2022
Link: https://doi.org/10.1136/..
 
?
13

Ensuring Patient Safety and Benefit in Use of Medical Devic..:

, In: The Future of Medical Device Regulation,
Dhruva, Sanket S. ; Darrow, Jonathan J. ; Kesselheim, Aaron S.. - p. 217-228 , 2022
Link: https://doi.org/10.1017/..
 
?
14

Generating Evidence from Expanded Access Use of Rare Diseas..:

Polak, Tobias B. ; Cucchi, David G. J. ; van Rosmalen, Joost..
Frontiers in Pharmacology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
15

Strategies to Manage Drugs and Devices Approved Based on Li..:

Dhruva, Sanket S. ; Darrow, Jonathan J. ; Kesselheim, Aaron S..
Clinical Pharmacology & Therapeutics.  111 (2022)  6 - p. 1307-1314 , 2022
Link: https://doi.org/10.1002/..
 
1-15